课题基金 / 基金详情

MOPP VS RADIOTHERAPY FOR EARLY STAGE HOGDKINS DISEASE

MOPP VS RADIOTHERAPY FOR EARLY STAGE HOGDKINS DISEASE
MOPP 与放射疗法治疗早期霍格金病
批准号：
2464509
负责人：
B L GAUSE
金额：
$0.0万
依托单位：
DIVISION OF CLINICAL SCIENCES - NCI
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/2464509
关键词：
Hodgkin's disease clinical research combination chemotherapy human subject human therapy evaluation mechlorethamine neoplasm /cancer chemotherapy neoplasm /cancer classification /staging neoplasm /cancer radiation therapy prednisone procarbazine vincristine

项目摘要

项目成果

B L GAUSE的其他基金

相似基金

相关文献

中文摘要
翻译
本研究旨在比较两种药物的反应率和毒性
英文摘要
This study was designed to compare the response rates and toxicities of MOPP chemotherapy vs. radiation in the management of previously untreated laparotomy-documented patients with early stage Hodgkin's disease. Of the 55 evaluable patients randomized to MOPP, 53 (96%) achieved a complete response; 7 relapsed. Fifty of the fifty-two randomized radiation-treated patients (96%) achieved a complete response: 19 patients (38%) relapsed. Four MOPP-treated patients (7%) and eleven (21%) radiation-treated patients have died. We continue to follow patients on study and assess long-term side effects of each therapy and long-term survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE I/II STUDY OF VACCINIA-HPV RECOMBINANT
PHASE IA/B TRIAL OF ANTICD3 AND INTERLEUKIN 2
PHASE I/II STUDY OF VACCINIA-HPV RECOMBINANT
OBSERVATION VS INTENSIVE CHEMOTHERAPY FOR INDOLENT LYMPHOMA
海外基金